Lois Bookhardt Murray
Internal Medicine · Bronx, NYNPI 1609805472
Payments from drug & device makers
Across 263 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- Viiv Healthcare Company$1K
- Novo Nordisk$639
- Medtronic$553
- Gilead$550
- Merck$388
- plus $897 from 12 others
What the payments were for
- Food & beverage$5,80799%
- Education$311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 78 | $1,767 |
| Viiv Healthcare Company | 50 | $1,045 |
| Novo Nordisk | 30 | $639 |
| Medtronic | 21 | $553 |
| Gilead | 27 | $550 |
| Merck | 17 | $388 |
| EMD Serono, Inc. | 14 | $294 |
| Janssen Products, LP | 2 | $156 |
| Lilly USA, LLC | 4 | $90 |
| GSK | 3 | $71 |
| Intercept Pharmaceuticals, Inc. | 3 | $68 |
| Theratechnologies Inc. | 3 | $64 |
| Dynavax Technologies Corporation | 6 | $46 |
| Dexcom, Inc. | 1 | $30 |
| Exact Sciences | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Bayer | 1 | $17 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Symtuza$125
How this compares
$5,838 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 143 | $572,644 |
| JulucaDolutegravir/Rilpivirine | 76 | $255,399 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 37 | $164,900 |
| CabenuvaCabotegravir/Rilpivirine | 23 | $148,936 |
| OzempicSemaglutide | 85 | $96,958 |
| JardianceEmpagliflozin | 93 | $87,127 |
| TrulicityDulaglutide | 48 | $57,828 |
| DescovyEmtricitabine/Tenofov Alafenam | 27 | $57,510 |
| JanuviaSitagliptin Phosphate | 60 | $54,185 |
| DovatoDolutegravir Sodium/Lamivudine | 17 | $49,530 |
| RybelsusSemaglutide | 35 | $48,428 |
| PrezcobixDarunavir/Cobicistat | 13 | $31,480 |
| Darunavir | 16 | $18,499 |
| Diclofenac Sodium | 83 | $16,670 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 54 | $15,593 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $550 | $630,154170 claims |
| Viiv Healthcare CompanyJuluca, Cabenuva, Dovato | $1,045 | $453,865116 claims |
| Janssen Products, LPSymtuza | $156 | $164,90037 claims |
| Novo NordiskOzempic, Rybelsus | $639 | $145,386120 claims |
| MerckJanuvia, Janumet | $388 | $69,53878 claims |
| Lilly USA, LLCTrulicity | $90 | $57,82848 claims |
| GSKTrelegy Ellipta, Incruse Ellipta, Shingrix, Breo Ellipta, Arnuity Ellipta | $71 | $35,10499 claims |
| Johnson & JohnsonPrezcobix | $1,767 | $31,48013 claims |
| PfizerEliquis | $15 | $14,25718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Bronx
- Benjamin GartrellBronx$6.3M
- David SteinBronx$2.4M
- Haiying ChengBronx$1.7M
- Jason LeiderBronx$1.4M
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.